Rheumatoid arthritis which type of hypersensitivity
Rheumatoid arthritis (RA) is a Type III hypersensitivity (immune complex-mediated) reaction, with a significant Type IV (cell-mediated) component as well.
Searching sources...
Reading File
Finding Sources
Finding Sources
The Cellular and Molecular Immunology textbook has a dedicated Hypersensitivity chapter mentioning RA directly. Let me read that section.
Reading File
Finding Sources
Let me read the detailed RA hypersensitivity content from Robbins and the Cellular Immunology textbook.
Reading File
Reading File
Let me read the specific RA section from the Cellular Immunology book and Robbins pathology.
Reading File
Reading File
I now have excellent textbook content. Let me also read the specific RA section from the same book to get the full picture.
Reading File
Reading File
I now have excellent, detailed content from the textbooks. Let me compile the full answer.
Rheumatoid Arthritis - Type of Hypersensitivity
Rheumatoid arthritis (RA) primarily involves Type III (Immune Complex-Mediated) and Type IV (T Cell-Mediated) hypersensitivity. For most exam purposes, Type III is cited as the classic answer, but the full picture is more nuanced.
Type III Hypersensitivity (Immune Complex-Mediated) - the classic answer
As stated in K.J. Lee's Essential Otolaryngology: "Type III (immune complex) reactions...include Rheumatoid arthritis, serum sickness, and lupus."
The mechanism in RA:
- Rheumatoid factors (RF): Auto-antibodies (usually IgM) directed against the Fc portion of the patient's own IgG molecules. These form IgM-IgG immune complexes that deposit in synovial tissue.
- Anti-citrullinated protein antibodies (ACPAs): Found in 60-80% of patients (seropositive RA), these form immune complexes with citrullinated proteins (vimentin, fibrinogen, etc.).
- Immune complex deposition activates complement (C3a, C5a), recruiting neutrophils and macrophages into the synovium, causing chronic inflammatory joint destruction.
Type IV Hypersensitivity (T Cell-Mediated) - equally important
From Cellular and Molecular Immunology (Abbas), RA is explicitly listed in the T Cell-Mediated Diseases table (Table 19.4):
| Disease | Pathogenic T cells | Mechanism |
|---|---|---|
| Rheumatoid arthritis | Against collagen? Citrullinated self proteins? | Inflammation mediated by Th1 and Th17 cytokines; role of antibodies and immune complexes |
The T cell-driven mechanism:
- CD4+ Th1 cells produce IFN-γ, activating macrophages in the synovium
- Th17 cells secrete IL-17, recruiting neutrophils and inducing synovial cells to release collagenases
- Net result: progressive cartilage and bone destruction
- Susceptibility is linked to HLA-DR4 (shared epitope), reinforcing the T cell-antigen presentation axis
Gell & Coombs Classification - Summary
| Type | Name | Mechanism | Role in RA |
|---|---|---|---|
| Type I | IgE-mediated | Mast cell degranulation | Not involved |
| Type II | Antibody vs. cell surface Ag | Complement/ADCC lysis | Minor (anti-RF targeting Fc) |
| Type III | Immune complex | IgG/IgM complexes + complement | Classic - synovial deposition of RF & ACPA complexes |
| Type IV | T cell-mediated | Th1/Th17 cytokines, macrophage activation | Major driver of chronic joint destruction |
Key Points for Exams
- Short answer: Type III hypersensitivity (immune complex-mediated)
- Complete answer: Type III + Type IV
- Rheumatoid factor = IgM antibody against Fc of IgG = hallmark immune complex in RA
- HLA association: HLA-DR4 (shared epitope) - links to Type IV T cell response
- Seropositive RA (RF+ and/or ACPA+) = more severe, stronger Type III component
Sources: - Cellular and Molecular Immunology (Abbas), Table 19.4 & pp. 1279-1282 | - K.J. Lee's Essential Otolaryngology, Immunology and Allergy chapter | - Robbins & Kumar Basic Pathology, Chapter 5
This is a shared conversation. Sign in to Orris to start your own chat.